7Baggers
 Atea Pharma (AVIR) Earnings Call Transcript  AOL.com Mon, 17 Nov 2025 19:04:39 GMT
 atea pharma (avir) earnings call transcript  AOL.com Fri, 14 Nov 2025 01:04:41 GMT
 atea pharma (avir) earnings call transcript  The Motley Fool Thu, 13 Nov 2025 17:18:00 GMT
 Atea Pharmaceuticals Advances Antiviral Programs with New Data  TipRanks Thu, 13 Nov 2025 04:07:31 GMT
 atea pharmaceuticals q3 2025 earnings call transcript  MarketBeat Thu, 13 Nov 2025 03:51:51 GMT
 Earnings call transcript: Atea Pharmaceuticals Q3 2025 sees EPS miss  Investing.com India Wed, 12 Nov 2025 22:46:28 GMT
 atea pharmaceuticals, inc. sec 10-q report  TradingView Wed, 12 Nov 2025 21:48:08 GMT
 Atea Pharmaceuticals, Inc. (AVIR) Q3 FY2025 earnings call transcript  Yahoo Finance Wed, 12 Nov 2025 21:30:00 GMT
 Atea Pharmaceuticals : Q3 Slides November 12 2025 FINAL  MarketScreener Wed, 12 Nov 2025 21:16:56 GMT
 Atea Pharmaceuticals announces presentation of data on BEM, RZR  TipRanks Fri, 07 Nov 2025 08:00:00 GMT
 Atea Pharmaceuticals to Host Third Quarter 2025 Financial  GlobeNewswire Wed, 05 Nov 2025 12:00:00 GMT
 Atea Pharmaceuticals’ New HCV Study: Potential Game-Changer?  TipRanks Mon, 27 Oct 2025 07:00:00 GMT

Atea Pharmaceuticals, Inc
(NASDAQ:AVIR) 

AVIR stock logo

Atea Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focused on discovering, developing, and commercializing antiviral therapeutics for patients suffering from viral infections. Its lead product candidate is AT-527, a novel antiviral agent that is in Phase II clinical trial for th...

CEO: Jean-Pierre Sommadossi  
Sector: Healthcare
Industry: Biotechnology

Share this website to your friends